Cargando…

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition

Peritoneal metastasis (PM) is a debilitating consequence of multiple cancers. As cancer cells lose tonic signaling related to attachment dependence, critical morphologic shifts result in alteration of the transcriptome. Identifying key genes associated with this transformation may lead to targeted t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spaeth-Cook, Douglas, Burch, Mark, Belton, Robin, Demoret, Bryce, Grosenbacher, Nicholas, David, Jason, Stets, Colin, Cohen, David, Shakya, Reena, Hays, John L., Chen, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235015/ https://www.ncbi.nlm.nih.gov/pubmed/30479697 http://dx.doi.org/10.18632/oncotarget.26281

Ejemplares similares

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
por: Seligson, Nathan D., et al.
Publicado: (2019)

MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models
por: Patt, Andrew, et al.
Publicado: (2020)

Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors
por: Faes, Seraina, et al.
Publicado: (2016)

Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis
por: Oberacker, Tina, et al.
Publicado: (2022)

Dual regulation of TxNIP by ChREBP and FoxO1 in liver
por: Noblet, Benedicte, et al.
Publicado: (2021)

N-Lobe of TXNIP Is Critical in the Allosteric Regulation of NLRP3 via TXNIP Binding
por: Cheng, Fengyu, et al.
Publicado: (2022)

Deletion of Thioredoxin-Interacting Protein (TXNIP) Abrogates High Fat Diet-Induced Retinal Leukostasis, Barrier Dysfunction and Microvascular Degeneration in a Mouse Obesity Model
por: Mohamed, Islam N., et al.
Publicado: (2020)

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes
por: Demoret, Bryce, et al.
Publicado: (2019)

ODP251 Thioredoxin-Interacting Protein (Txnip) And Cellular Senescence: Potential Adverse Effects of Txnip Deficiency.
por: Abubaker, Mohammed, et al.
Publicado: (2022)

TXNIP Regulates Peripheral Glucose Metabolism in Humans
por: Parikh, Hemang, et al.
Publicado: (2007)

mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)

Signaling Pathway of Taurine-Induced Upregulation of TXNIP
por: Satsu, Hideo, et al.
Publicado: (2022)

Induction of the Metabolic Regulator Txnip in Fasting-Induced and Natural Torpor
por: Hand, Laura E., et al.
Publicado: (2013)

AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa
por: Xue, Yunlu, et al.
Publicado: (2021)

Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy
por: Perrone, L, et al.
Publicado: (2010)

Hemodialysis Serum Stimulates the TXNIP-eNOS-STAT3 Inflammatory Pathway In Vitro
por: Cohen-Hagai, Keren, et al.
Publicado: (2023)

TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
por: Alhawiti, Naif Mohammad, et al.
Publicado: (2017)

Identification of Redox and Glucose-Dependent Txnip Protein Interactions
por: Forred, Benjamin J., et al.
Publicado: (2016)

Comparison of anti-peritoneal fibrotic effects between an mTORC1-specific blocker and a PI3K/mTOR dual-blocker
por: Xu, Tian, et al.
Publicado: (2019)

Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer
por: Mirkheshti, Nooshin, et al.
Publicado: (2016)

Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions
por: Mousa, Shaker A., et al.
Publicado: (2009)

New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats
por: Ding, Chunchun, et al.
Publicado: (2016)

A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models
por: Zhang, Hao, et al.
Publicado: (2013)

Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
por: Yoshihara, Eiji, et al.
Publicado: (2014)

Role of TXNIP/NLRP3 in sepsis-induced myocardial dysfunction
por: Yang, Chun, et al.
Publicado: (2019)

TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis
por: Yoshihara, Eiji
Publicado: (2020)

Oxidative stress-mediated TXNIP loss causes RPE dysfunction
por: Ji Cho, Min, et al.
Publicado: (2019)

Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
por: Tsubaki, Haruka, et al.
Publicado: (2020)

TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook
por: Pan, Min, et al.
Publicado: (2022)

The Role of Txnip in Mediating Low-Magnesium-Driven Endothelial Dysfunction
por: Locatelli, Laura, et al.
Publicado: (2023)

Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T‐cell leukemia
por: Kawata, Takahito, et al.
Publicado: (2017)

Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
por: Peters, Nathan C., et al.
Publicado: (2009)

RAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
por: Sbai, Oualid, et al.
Publicado: (2022)

Dual roles of mTORC1-dependent activation of the ubiquitin-proteasome system in muscle proteostasis
por: Kaiser, Marco S., et al.
Publicado: (2022)

Suppression of mTORC1 activity in senescent Ras-transformed cells neither restores autophagy nor abrogates apoptotic death caused by inhibition of MEK/ERK kinases
por: Kochetkova, Elena Y., et al.
Publicado: (2018)

Central Suppression of the GH/IGF Axis and Abrogation of Exercise-Related mTORC1/2 Activation in the Muscle of Phenotype-Selected Male Marathon Mice (DUhTP)
por: Brenmoehl, Julia, et al.
Publicado: (2021)

Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis
por: Tasneen, Rokeya, et al.
Publicado: (2021)

TXNIP shuttling: missing link between oxidative stress and inflammasome activation
por: Lane, Troy, et al.
Publicado: (2013)

Cutting Calories and TXNIP From the Skeletal Muscle to Restore Insulin Sensitivity
por: Anderson, Ethan J.
Publicado: (2016)

A role for thioredoxin-interacting protein (Txnip) in cellular creatine homeostasis
por: Zervou, Sevasti, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gqoqom3957shvkodvi6eg9t6ev